Volume | 630,680 |
|
|||||
News | - | ||||||
Day High | 528.42 | Low High |
|||||
Day Low | 514.88 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
McKesson Corporation | MCK | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
528.42 | 514.88 | 528.42 | 518.81 | 525.92 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
20,563 | 630,680 | $ 520.06 | $ 327,992,936 | - | 352.34 - 543.00 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:53:00 | 1 | $ 519.96 | USD |
McKesson (MCK) Options Flow Summary
McKesson Corporation Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
68.18B | 131.41M | - | 276.72B | 3.56B | 27.09 | 19.15 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
McKesson News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical MCK Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 530.51 | 532.00 | 514.88 | 524.55 | 443,756 | -11.51 | -2.17% |
1 Month | 530.00 | 543.00 | 514.88 | 532.09 | 469,568 | -11.00 | -2.08% |
3 Months | 484.16 | 543.00 | 478.65 | 517.49 | 684,719 | 34.84 | 7.20% |
6 Months | 457.84 | 543.00 | 431.35 | 484.46 | 750,709 | 61.16 | 13.36% |
1 Year | 363.92 | 543.00 | 352.34 | 444.58 | 789,949 | 155.08 | 42.61% |
3 Years | 194.23 | 543.00 | 180.415 | 330.99 | 966,947 | 324.77 | 167.21% |
5 Years | 112.56 | 543.00 | 111.91 | 230.63 | 1,281,371 | 406.44 | 361.09% |
McKesson Description
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies. |